P1197: BRUTON’S TYROSINE KINASE INHIBITOR ZANUBRUTINIB IN RELAPSED/REFRACTORY PRIMARY DIFFUSE LARGE B-CELL LYMPHOMA OF CENTRAL NERVOUS SYSTEM: A PHASE II TRIAL

Bibliographic Details
Main Authors: Yali Wang, Wenbin LI, Feng Chen
Format: Article
Language:English
Published: Wiley 2023-08-01
Series:HemaSphere
Online Access:http://journals.lww.com/10.1097/01.HS9.0000971684.84535.92
_version_ 1797280204763168768
author Yali Wang
Wenbin LI
Feng Chen
author_facet Yali Wang
Wenbin LI
Feng Chen
author_sort Yali Wang
collection DOAJ
first_indexed 2024-03-07T16:36:44Z
format Article
id doaj.art-c734e8fdc60d4d698ed3cefecb2f94c6
institution Directory Open Access Journal
issn 2572-9241
language English
last_indexed 2024-03-07T16:36:44Z
publishDate 2023-08-01
publisher Wiley
record_format Article
series HemaSphere
spelling doaj.art-c734e8fdc60d4d698ed3cefecb2f94c62024-03-03T09:43:15ZengWileyHemaSphere2572-92412023-08-017e845359210.1097/01.HS9.0000971684.84535.92202308003-01095P1197: BRUTON’S TYROSINE KINASE INHIBITOR ZANUBRUTINIB IN RELAPSED/REFRACTORY PRIMARY DIFFUSE LARGE B-CELL LYMPHOMA OF CENTRAL NERVOUS SYSTEM: A PHASE II TRIALYali Wang0Wenbin LI1Feng Chen21 Beijing tiantan hospital, Department of Neuro-oncology, Cancer Center,, BEIJING, China1 Beijing tiantan hospital, Department of Neuro-oncology, Cancer Center,, BEIJING, China3 Beijing tiantan hospital, Department of Neuro-oncology, Cancer Center,, Beijing, Chinahttp://journals.lww.com/10.1097/01.HS9.0000971684.84535.92
spellingShingle Yali Wang
Wenbin LI
Feng Chen
P1197: BRUTON’S TYROSINE KINASE INHIBITOR ZANUBRUTINIB IN RELAPSED/REFRACTORY PRIMARY DIFFUSE LARGE B-CELL LYMPHOMA OF CENTRAL NERVOUS SYSTEM: A PHASE II TRIAL
HemaSphere
title P1197: BRUTON’S TYROSINE KINASE INHIBITOR ZANUBRUTINIB IN RELAPSED/REFRACTORY PRIMARY DIFFUSE LARGE B-CELL LYMPHOMA OF CENTRAL NERVOUS SYSTEM: A PHASE II TRIAL
title_full P1197: BRUTON’S TYROSINE KINASE INHIBITOR ZANUBRUTINIB IN RELAPSED/REFRACTORY PRIMARY DIFFUSE LARGE B-CELL LYMPHOMA OF CENTRAL NERVOUS SYSTEM: A PHASE II TRIAL
title_fullStr P1197: BRUTON’S TYROSINE KINASE INHIBITOR ZANUBRUTINIB IN RELAPSED/REFRACTORY PRIMARY DIFFUSE LARGE B-CELL LYMPHOMA OF CENTRAL NERVOUS SYSTEM: A PHASE II TRIAL
title_full_unstemmed P1197: BRUTON’S TYROSINE KINASE INHIBITOR ZANUBRUTINIB IN RELAPSED/REFRACTORY PRIMARY DIFFUSE LARGE B-CELL LYMPHOMA OF CENTRAL NERVOUS SYSTEM: A PHASE II TRIAL
title_short P1197: BRUTON’S TYROSINE KINASE INHIBITOR ZANUBRUTINIB IN RELAPSED/REFRACTORY PRIMARY DIFFUSE LARGE B-CELL LYMPHOMA OF CENTRAL NERVOUS SYSTEM: A PHASE II TRIAL
title_sort p1197 bruton s tyrosine kinase inhibitor zanubrutinib in relapsed refractory primary diffuse large b cell lymphoma of central nervous system a phase ii trial
url http://journals.lww.com/10.1097/01.HS9.0000971684.84535.92
work_keys_str_mv AT yaliwang p1197brutonstyrosinekinaseinhibitorzanubrutinibinrelapsedrefractoryprimarydiffuselargebcelllymphomaofcentralnervoussystemaphaseiitrial
AT wenbinli p1197brutonstyrosinekinaseinhibitorzanubrutinibinrelapsedrefractoryprimarydiffuselargebcelllymphomaofcentralnervoussystemaphaseiitrial
AT fengchen p1197brutonstyrosinekinaseinhibitorzanubrutinibinrelapsedrefractoryprimarydiffuselargebcelllymphomaofcentralnervoussystemaphaseiitrial